• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白AII rs5082变体与澳大利亚男性人群中冠状动脉疾病风险降低相关。

The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population.

作者信息

Xiao Jing, Zhang Fan, Wiltshire Steven, Hung Joseph, Jennens Michelle, Beilby John P, Thompson Peter L, McQuillan Brendan M, McCaskie Pamela A, Carter Kim W, Palmer Lyle J, Powell Brenda L

机构信息

Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Australia.

出版信息

Atherosclerosis. 2008 Aug;199(2):333-9. doi: 10.1016/j.atherosclerosis.2007.11.017. Epub 2008 Jan 7.

DOI:10.1016/j.atherosclerosis.2007.11.017
PMID:18179799
Abstract

Serum high density lipoprotein (HDL) levels are inversely related to the development of coronary artery disease (CAD). Apolipoproteins AI and AII are the major protein constituents of HDL particles. APOAI and APOAII genetic polymorphisms have been proposed to affect transcriptional efficiency of their respective genes, thereby altering serum lipid levels and influencing atherosclerotic disease risk. 556 subjects with angiographically proven CAD (>50% stenosis) and 1109 randomly selected individuals from metropolitan Perth, Western Australia, were included in an association study. APOAI -75G/A (rs670) and APOAII -256T/C (rs5082) polymorphisms were both found to be not associated with plasma HDL levels. In a case-control analysis of 484 male CAD patients and 498 male controls, individuals carrying the 'CC' genotype for the APOAII rs5082 polymorphism had significantly lower risk of CAD than the 'T' allele carriers (OR=0.57, 95% CI 0.39-0.84, p=0.004). The minor 'A' allele of the APOAI rs670 polymorphism was found to be not associated with CAD, contrary to previous reports. We conclude that the APOAII rs5082 polymorphism appears to be cardioprotective in this representative Caucasian Australian population.

摘要

血清高密度脂蛋白(HDL)水平与冠状动脉疾病(CAD)的发生呈负相关。载脂蛋白AI和AII是HDL颗粒的主要蛋白质成分。有人提出APOAI和APOAII基因多态性会影响各自基因的转录效率,从而改变血脂水平并影响动脉粥样硬化疾病风险。一项关联研究纳入了556名经血管造影证实患有CAD(狭窄>50%)的受试者以及1109名从澳大利亚西部珀斯市随机选取的个体。研究发现,APOAI -75G/A(rs670)和APOAII -256T/C(rs5082)多态性均与血浆HDL水平无关。在对484名男性CAD患者和498名男性对照进行的病例对照分析中,携带APOAII rs5082多态性“CC”基因型的个体患CAD的风险显著低于“T”等位基因携带者(OR = 0.57,95% CI 0.39 - 0.84,p = 0.004)。与之前的报道相反,APOAI rs670多态性的次要“A”等位基因与CAD无关。我们得出结论,在这个具有代表性的澳大利亚白种人群体中,APOAII rs5082多态性似乎具有心脏保护作用。

相似文献

1
The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population.载脂蛋白AII rs5082变体与澳大利亚男性人群中冠状动脉疾病风险降低相关。
Atherosclerosis. 2008 Aug;199(2):333-9. doi: 10.1016/j.atherosclerosis.2007.11.017. Epub 2008 Jan 7.
2
A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.载脂蛋白A5基因中的一种基因变异c.553G>T与中国人群中冠状动脉疾病风险增加及甘油三酯水平改变有关。
Atherosclerosis. 2006 Apr;185(2):433-7. doi: 10.1016/j.atherosclerosis.2005.06.026. Epub 2005 Jul 25.
3
The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.载脂蛋白ε4和ε2等位基因的存在会增加2型糖尿病患者患冠状动脉疾病的风险。
Clin Biochem. 2007 Oct;40(15):1150-6. doi: 10.1016/j.clinbiochem.2007.06.010. Epub 2007 Jul 6.
4
Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.土耳其冠心病患者载脂蛋白B基因的遗传变异
Ann Hum Biol. 2005 Sep-Oct;32(5):620-9. doi: 10.1080/03014460500228626.
5
Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.载脂蛋白:与颈动脉内膜中层厚度及冠状动脉疾病的相关性
J Assoc Physicians India. 2004 May;52:370-5.
6
Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.胆固醇酯转运蛋白-629C>A多态性与冠心病患者高密度脂蛋白胆固醇水平的关联
Cell Biochem Funct. 2009 Oct;27(7):452-7. doi: 10.1002/cbf.1593.
7
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.载脂蛋白AII在转基因小鼠中的过表达会将高密度脂蛋白转变为促炎颗粒。
J Clin Invest. 1997 Jul 15;100(2):464-74. doi: 10.1172/JCI119554.
8
A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.汉族人群载脂蛋白M基因T-778C多态性与冠状动脉疾病关系的前瞻性评估
Clin Biochem. 2007 Oct;40(15):1108-12. doi: 10.1016/j.clinbiochem.2007.04.023. Epub 2007 Jul 4.
9
The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.台湾人群中冠状动脉疾病的风险与人类对氧磷酶(PON)-2基因的Cys-Ser 311多态性相关。
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Sep;65(9):415-21.
10
Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease.克罗地亚冠心病患者的脂蛋白脂肪酶基因多态性
Clin Chem Lab Med. 2003 Apr;41(4):541-6. doi: 10.1515/CCLM.2003.082.

引用本文的文献

1
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling.缩小血脂异常患者管理中的差距:通过载脂蛋白分析迈向心血管精准诊断。
Clin Proteomics. 2024 Mar 1;21(1):19. doi: 10.1186/s12014-024-09465-w.
2
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research.载脂蛋白 A1 和 A2 蛋白水解物的解析:其与心血管代谢的相关性及其对未来研究的意义。
Curr Opin Lipidol. 2022 Aug 1;33(4):264-269. doi: 10.1097/MOL.0000000000000840.
3
Apolipoprotein A-II, a Player in Multiple Processes and Diseases.
载脂蛋白A-II,多种生理过程和疾病中的参与者。
Biomedicines. 2022 Jul 2;10(7):1578. doi: 10.3390/biomedicines10071578.
4
Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study.载脂蛋白 AI 和载脂蛋白 AII 蛋白亚型谱及其与心脏代谢健康指标的关系:CARDIA 研究。
J Am Heart Assoc. 2021 Sep 7;10(17):e019890. doi: 10.1161/JAHA.120.019890. Epub 2021 Sep 2.
5
Interaction between Apo A-II -265T>C polymorphism and dietary total antioxidant capacity on some anthropometric indices and serum lipid profile in patients with type 2 diabetes mellitus.载脂蛋白 A-II-265T>C 多态性与饮食总抗氧化能力在 2 型糖尿病患者某些人体测量指数和血脂谱中的相互作用。
J Nutr Sci. 2021 Feb 9;10:e9. doi: 10.1017/jns.2020.61. eCollection 2021.
6
Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction.载脂蛋白A2亚型:对心肌梗死风险的新见解。
J Atheroscler Thromb. 2021 May 1;28(5):469-470. doi: 10.5551/jat.ED150. Epub 2020 Nov 13.
7
Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances.维生素 E 的代谢作用和遗传变异:肥胖及相关紊乱精准营养的挑战。
Nutrients. 2018 Dec 4;10(12):1919. doi: 10.3390/nu10121919.
8
APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus.载脂蛋白A2 -265T/C多态性与2型糖尿病患者炎症反应增加有关。
Diabetes Metab J. 2016 Jun;40(3):222-9. doi: 10.4093/dmj.2016.40.3.222.
9
Identification of Sequence Variation in the Apolipoprotein A2 Gene and Their Relationship with Serum High-Density Lipoprotein Cholesterol Levels.载脂蛋白A2基因序列变异的鉴定及其与血清高密度脂蛋白胆固醇水平的关系。
Iran Biomed J. 2016;20(2):84-90. doi: 10.7508/ibj.2016.02.003. Epub 2015 Nov 16.
10
Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?载脂蛋白A-II:在高密度脂蛋白代谢中仍居次要地位?
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):166-7. doi: 10.1161/ATVBAHA.112.300921.